CbdMD Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . cbdMD Inc
YCBD Stock  USD 0.92  0.02  2.13%   
CbdMD's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CbdMD's valuation are provided below:
Gross Profit
11.6 M
Profit Margin
(0.08)
Market Capitalization
6.6 M
Enterprise Value Revenue
0.437
Revenue
19 M
There are over one hundred nineteen available fundamental signals for cbdMD Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of CbdMD's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Enterprise Value is expected to grow to about 942.9 M, whereas Market Cap is forecasted to decline to about 5.3 M.

CbdMD Total Revenue

22.32 Million

Check CbdMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CbdMD's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 98.9 K or Interest Expense of 32.2 K, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.21 or PTB Ratio of 7.0E-4. CbdMD financial statements analysis is a perfect complement when working with CbdMD Valuation or Volatility modules.
  
Build AI portfolio with CbdMD Stock
Check out the analysis of CbdMD Correlation against competitors.

CbdMD Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.4 M12 M27.3 M
Pretty Stable
Short and Long Term Debt Total939.7 M895 M155.3 M
Slightly volatile
Other Current Liabilities2.3 B2.2 B377.8 M
Slightly volatile
Total Current Liabilities3.9 B3.7 B633.4 M
Slightly volatile
Total Stockholder Equity8.7 B8.3 B1.4 B
Slightly volatile
Property Plant And Equipment Net1.1 M1.2 M2.1 M
Slightly volatile
Accounts Payable1.7 M1.3 M1.2 M
Slightly volatile
Cash2.5 M2.6 M4.2 M
Pretty Stable
Non Current Assets Total4.2 M4.4 M18.5 M
Pretty Stable
Cash And Short Term Investments2.5 M2.6 M4.6 M
Pretty Stable
Net Receivables1.5 M1.2 M1 M
Slightly volatile
Common Stock Total Equity62.9 K60 K29.1 K
Slightly volatile
Liabilities And Stockholders Equity11.4 M12 M27.3 M
Pretty Stable
Capital Surpluse117.4 M111.8 M56.4 M
Slightly volatile
Inventory2.9 M3.1 M2.1 M
Slightly volatile
Other Current Assets3.9 M3.7 M1.6 M
Slightly volatile
Other Stockholder Equity225.6 B214.9 B37 B
Slightly volatile
Total Liabilities3.5 M3.7 M9 M
Pretty Stable
Property Plant And Equipment Gross4.2 M3.8 M3 M
Slightly volatile
Total Current Assets13.1 M7.5 M9.2 M
Slightly volatile
Short Term Debt940.7 M895.9 M154.5 M
Slightly volatile
Intangible Assets2.3 M2.4 M6.3 M
Pretty Stable
Common Stock10.8 M10.3 M1.8 M
Slightly volatile
Property Plant Equipment3.5 M6.1 M3 M
Slightly volatile
Common Stock Shares Outstanding4.9 M4.6 M1.5 M
Slightly volatile
Short and Long Term Debt1.1 M1.1 M764.7 K
Very volatile
Current Deferred Revenue611.3 M582.2 M100.1 M
Slightly volatile
Long Term Debt424.1 K692.4 K449.3 K
Slightly volatile
Net Invested Capital6.2 M6.5 M19.4 M
Pretty Stable
Other Liabilities340.7 K358.6 K4.9 M
Very volatile
Other Assets209.1 K220.1 K1.9 M
Slightly volatile
Capital Stock9.1 K9.6 K18.8 K
Pretty Stable
Non Current Liabilities Other77.3 K81.3 K4.6 M
Very volatile
Capital Lease Obligations665.4 K700.4 K5.2 M
Slightly volatile

CbdMD Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income98.9 K57.3 K76.4 K
Very volatile
Total Revenue22.3 M22.1 M15.7 M
Slightly volatile
Gross Profit14 M12.5 M9.8 M
Slightly volatile
Cost Of Revenue8.3 M9.6 M5.9 M
Slightly volatile
Depreciation And Amortization1.6 M2.1 M1.1 M
Slightly volatile
Other Operating Expenses34.2 M24.6 M23.4 M
Slightly volatile
Total Operating Expenses26.5 M15 M17.8 M
Slightly volatile
Reconciled Depreciation1.6 M2.1 M1 M
Slightly volatile
Selling General Administrative11.8 M6.3 M8.7 M
Slightly volatile
Selling And Marketing Expenses6.9 M4 M5 M
Slightly volatile
Research Development28.9 K30.5 K388.6 K
Slightly volatile

CbdMD Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.4 B1.3 B223.1 M
Slightly volatile
Capital Expenditures222.4 M211.8 M36.8 M
Slightly volatile
End Period Cash Flow2.7 B2.6 B450.4 M
Slightly volatile
Stock Based Compensation12.1 K12.7 K584.7 K
Pretty Stable
Begin Period Cash Flow3 B2.8 B488 M
Slightly volatile
Issuance Of Capital Stock1.2 M1.3 M10.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.280.2942.7374
Slightly volatile
Dividend Yield0.210.20.0654
Slightly volatile
PTB Ratio7.0E-48.0E-4187
Slightly volatile
Days Sales Outstanding21.6322.7737.98
Pretty Stable
Average Payables1.6 M1.6 M1.3 M
Slightly volatile
Stock Based Compensation To Revenue9.0E-40.0010.0255
Very volatile
Capex To Depreciation0.180.191.5904
Slightly volatile
PB Ratio7.0E-48.0E-4187
Slightly volatile
EV To Sales34.5746.7949.9232
Slightly volatile
Inventory Turnover5.263.643.9336
Very volatile
Days Of Inventory On Hand101104131
Slightly volatile
Payables Turnover4.226.46.0424
Slightly volatile
Sales General And Administrative To Revenue0.340.330.3332
Slightly volatile
Average Inventory1.3 M1.4 M2.6 M
Very volatile
Research And Ddevelopement To Revenue0.00220.00230.0098
Pretty Stable
Capex To Revenue9.078.641.642
Slightly volatile
Cash Per Share0.610.656.3306
Very volatile
Days Payables Outstanding83.5559.0166.738
Slightly volatile
Intangibles To Total Assets0.450.230.3666
Pretty Stable
Current Ratio0.00220.00242.625
Pretty Stable
Receivables Turnover15.616.5917.006
Slightly volatile
Shareholders Equity Per Share1.7 K1.6 K325
Slightly volatile
Debt To Equity0.120.10770.3061
Pretty Stable
Capex Per Share43.2741.218.706
Slightly volatile
Average Receivables741.4 K911.2 K775.6 K
Slightly volatile
Revenue Per Share5.215.4923.877
Slightly volatile
Interest Debt Per Share18317437.5293
Slightly volatile
Debt To Assets70.5867.2212.6198
Slightly volatile
Graham Number122137150
Slightly volatile
Operating Cycle21.6322.77151
Slightly volatile
Price Book Value Ratio7.0E-48.0E-4187
Slightly volatile
Days Of Payables Outstanding83.5559.0166.738
Slightly volatile
Company Equity Multiplier0.00160.00171.6168
Pretty Stable
Long Term Debt To Capitalization0.00820.00870.037
Slightly volatile
Total Debt To Capitalization0.220.110.1844
Very volatile
Debt Equity Ratio0.120.10770.3061
Pretty Stable
Quick Ratio0.00220.00242.2196
Pretty Stable
Cash Ratio8.0E-48.0E-41.0953
Pretty Stable
Days Of Inventory Outstanding101104131
Slightly volatile
Days Of Sales Outstanding21.6322.7737.98
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio12011422.1419
Slightly volatile
Price To Book Ratio7.0E-48.0E-4187
Slightly volatile
Fixed Asset Turnover31.1621.1423.0568
Very volatile
Debt Ratio70.5867.2212.6198
Slightly volatile
Price Sales Ratio0.280.2942.7374
Slightly volatile
Asset Turnover1.741.661.1252
Slightly volatile
Gross Profit Margin0.470.510.4664
Slightly volatile
Price Fair Value7.0E-48.0E-4187
Slightly volatile

CbdMD Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.3 M5.6 M324.7 M
Slightly volatile
Enterprise Value942.9 M898 M473.2 M
Slightly volatile

CbdMD Fundamental Market Drivers

Forward Price Earnings714.2857
Cash And Short Term Investments2.3 M

CbdMD Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About CbdMD Financial Statements

CbdMD stakeholders use historical fundamental indicators, such as CbdMD's revenue or net income, to determine how well the company is positioned to perform in the future. Although CbdMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in CbdMD's assets and liabilities are reflected in the revenues and expenses on CbdMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in cbdMD Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue582.2 M611.3 M
Total Revenue22.1 M22.3 M
Cost Of Revenue9.6 M8.3 M
Sales General And Administrative To Revenue 0.33  0.34 
Capex To Revenue 8.64  9.07 
Revenue Per Share 5.49  5.21 
Ebit Per Revenue(0.10)(0.11)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
How To Invest In CbdMD
Details
Is CbdMD Stock a good investment?
Details
What is CbdMD's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of CbdMD Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Pharmaceuticals sector continue expanding? Could CbdMD diversify its offerings? Factors like these will boost the valuation of CbdMD. Anticipated expansion of CbdMD directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CbdMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
0.51
Revenue Per Share
9.412
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.09)
Return On Equity
(0.33)
cbdMD Inc's market price often diverges from its book value, the accounting figure shown on CbdMD's balance sheet. Smart investors calculate CbdMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CbdMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY